Nanomedicines reveal how PBOV1 promotes hepatocellular carcinoma for effective gene therapy

Novel therapeutic strategies are needed to improve the treatment outcome of hepatocellular carcinoma. Here, the authors develop a theranostical targeted nanomedicine platform that reveals the key oncogenic role of PBOV1 in hepatocellular carcinoma.

Saved in:
Bibliographic Details
Main Authors: Yu Guo, Zhiqiang Wu, Shunli Shen, Ruomi Guo, Jing Wang, Weiwei Wang, Kun Zhao, Ming Kuang, Xintao Shuai
Format: article
Language:EN
Published: Nature Portfolio 2018
Subjects:
Q
Online Access:https://doaj.org/article/df628571a91a4d879af5c3772f6a5b78
Tags: Add Tag
No Tags, Be the first to tag this record!